Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease.
about
Chagas disease and transfusion medicine: a perspective from non-endemic countriesParasitic diseases of the central nervous system: lessons for clinicians and policy makers.Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients.Prevalence of Chagas Disease in the Latin American-born Population of Los AngelesCongenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia.Prevalence of antibody to Trypanosoma cruzi in Hispanic-surnamed patients seen at Parkland Health & Hospital System, Dallas, Texas.Excretory-secretory antigens of Trypanosoma cruzi are potentially useful for serodiagnosis of chronic Chagas' disease.Use of full-length recombinant calflagin and its c fragment for improvement of diagnosis of Trypanosoma cruzi infection.Genome-wide screening and identification of new Trypanosoma cruzi antigens with potential application for chronic Chagas disease diagnosis.Biomarkers in Trypanosoma cruzi-infected and uninfected individuals with varying severity of cardiomyopathy in Santa Cruz, Bolivia.Use of a novel chagas urine nanoparticle test (chunap) for diagnosis of congenital chagas disease.Purified excreted-secreted antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis of Chagas' diseaseCell death and serum markers of collagen metabolism during cardiac remodeling in Cavia porcellus experimentally infected with Trypanosoma cruziMolecular epidemiology of human oral Chagas disease outbreaks in Colombia.Detection of soluble antigen and DNA of Trypanosoma cruzi in urine is independent of renal injury in the guinea pig modelCavia porcellus as a model for experimental infection by Trypanosoma cruziTrypanosoma cruzi-infected pregnant women without vector exposure have higher parasitemia levels: implications for congenital transmission risk.Prevalence and Transmission of Trypanosoma cruzi in People of Rural Communities of the High Jungle of Northern Peru.Human Trypanosoma cruzi infection and seropositivity in dogs, Mexico.Trypanosoma cruzi burden, genotypes, and clinical evaluation of Chilean patients with chronic Chagas cardiopathy.Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients.Sustained Domestic Vector Exposure Is Associated With Increased Chagas Cardiomyopathy Risk but Decreased Parasitemia and Congenital Transmission Risk Among Young Women in BoliviaEvaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.Development and Application of an ELISA Assay Using Excretion/Secretion Proteins from Epimastigote Forms of T. cruzi (ESEA Antigens) for the Diagnosis of Chagas DiseaseInterdisciplinary approach at the primary healthcare level for Bolivian immigrants with Chagas disease in the city of São Paulo.Profile of Trypanosoma cruzi reactivity in a population at high risk for endemic pemphigus foliaceus (Fogo selvagem)Field evaluation of a rapid immunochromatographic assay for detection of Trypanosoma cruzi infection by use of whole blood.Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.Aptamer based, non-PCR, non-serological detection of Chagas disease biomarkers in Trypanosoma cruzi infected mice.Prevalence of Trypanosoma cruzi infection among Bolivian immigrants in the city of São Paulo, Brazil.Chagas Disease Diagnostic Applications: Present Knowledge and Future Steps.Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection.Evaluation of a chemiluminescent enzyme-linked immunosorbent assay for the diagnosis of Trypanosoma cruzi infection in a nonendemic settingLeptomonas seymouri and Crithidia fasciculata exoantigens can discriminate human cases of visceral leishmaniasis from American tegumentary leishmaniasis ones.Towards improving early diagnosis of congenital Chagas disease in an endemic setting.The efficacy of L. (L.) chagasi excreted-secreted antigens (ESAs) for visceral leishmaniasis diagnosis is due to low levels of cross-reactivity.Evaluation of adult chronic Chagas' heart disease diagnosis by molecular and serological methodsEvaluation of recombinant antigens for serodiagnosis of Chagas' disease in South and Central America.Serodiagnosis of chronic and acute Chagas' disease with Trypanosoma cruzi recombinant proteins: results of a collaborative study in six Latin American countries.
P2860
Q26777968-2ABE1F3F-974E-4439-B278-636C802E64ABQ28077177-6802E031-2606-4523-9C91-A52B9DC60982Q30918385-910D7412-A607-4576-AD58-A36F5C518D00Q33589230-D885B862-3092-4CF6-B298-6A5D9008ED95Q33754264-013576F0-B7C2-4AE6-9E8C-91E82DB935A2Q33884894-F7306012-6C8D-4DF0-951E-E07D59F0AC57Q33999546-0B2BCCFD-9CB0-49A5-ADA8-83CAB6C9ED9AQ34143864-FA0CA8B3-3203-47C6-99DF-881319B0E1F1Q34194593-30162735-9914-404C-B77A-4BD0FF13A78AQ34281958-40B0F932-8C9B-4D18-80AA-5CDE03DA27C4Q34282008-822711CB-65F1-4523-852C-5C24554935F8Q34430612-866BA03D-9CA5-4BA1-92FC-8DCE17A5F7C5Q34587023-0279F525-16EC-41E3-9CEB-FA24153F4208Q34600658-7A585C50-FA8E-4709-9CAC-D638F87EC80AQ34631821-85938491-324F-48A9-9987-731B8637569CQ35069952-13675B98-9247-4E26-897A-5B51EECC6214Q35217173-C7581C02-BC09-499F-9CB1-4FB3F2221AFAQ35637312-19F1E63E-E6D1-40ED-B984-2E82CB29AD60Q35805548-C9BF9A4C-1F0A-4930-99E7-49A45914C3CFQ35884080-BDEDB234-9DBE-4865-B161-C17FC2971125Q35937351-96F8A125-4E22-4687-AAE7-3E4830B1CB5EQ35999719-D5C4DACA-C974-46F1-AFDC-B5C8280AD98FQ36097130-EFDB3D5F-2EBB-43E1-9D84-30029AF8C718Q36154765-E85F0088-6402-4C53-9A85-A60620A16683Q36294254-FC9AAE20-AF90-471C-B3D9-F757C00BF082Q36319603-E648CC30-0263-437C-A350-B39E5F45F854Q36450818-8AAC21AE-8EAE-42C5-A2C5-EB42D57AC4E9Q36747503-6EF623AB-5105-4F23-A1A5-D39FDE5A941AQ36869503-3F119D8E-00DA-40EA-9F5C-4DA8DFBA93E1Q37488022-716EE90F-FF4F-4691-87AE-5D5E247132C0Q37577142-72114049-3046-4649-9395-6740A1596E69Q37717875-EAC55C4D-BC86-40B4-BF59-EFD67DF1FAEBQ38480232-1D1430C7-D692-43A7-84C1-0BEB2B00F956Q38567777-1E4F93CD-8F50-4003-9FAB-4368EF32C012Q39129813-AD93E1D7-198E-4E5E-AEC8-B650E461400DQ39247280-FF9D133C-5C73-4C22-94A2-4F5A3E6ACB3DQ39356937-37FA0434-462A-4FFD-96FE-4227A827EA83Q39382689-DA6182AB-338D-4820-A5C4-4B0D3214C5ADQ39448889-EABC0800-5416-452C-B956-71D796381152Q39541793-DA401951-435F-466C-8201-9EE0762C7FC6
P2860
Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Immunoblot assay using excrete ...... , and chronic Chagas' disease.
@en
Immunoblot assay using excrete ...... , and chronic Chagas' disease.
@nl
type
label
Immunoblot assay using excrete ...... , and chronic Chagas' disease.
@en
Immunoblot assay using excrete ...... , and chronic Chagas' disease.
@nl
prefLabel
Immunoblot assay using excrete ...... , and chronic Chagas' disease.
@en
Immunoblot assay using excrete ...... , and chronic Chagas' disease.
@nl
P2093
P2860
P921
P1476
Immunoblot assay using excrete ...... , and chronic Chagas' disease.
@en
P2093
Borges-Pereira J
Camargo ME
Junqueira AC
Kesper N Jr
Nascimento MS
Umezawa ES
P2860
P304
P407
P577
1996-09-01T00:00:00Z